Athenex Profit Margin 2016-2021 | ATNX
Current and historical gross margin, operating margin and net profit margin for Athenex (ATNX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Athenex net profit margin as of June 30, 2021 is -121.58%.
|Athenex Annual Profit Margins
|Athenex Quarterly Profit Margins
||Medical - Biomedical and Genetics
Athenex, Inc. is a clinical stage biopharmaceutical company. It engaged in the discovery and development of drugs for the treatment of cancer. The company's platform including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. It operates primarily in Buffalo and Clarence, New York, Cranford, New Jersey, Houston, Texas, Chicago, Illinois, Hong Kong and Taipei Taiwan. Athenex, Inc. is based in Buffalo, United States.